The global radiation dose management market is projected to expand at a CAGR of ~7.9 percent across the forecast period of 2023 – 2029, according to the latest edition of the Global Radiation Dose Management Market Report. Radiation dose management refers to the practice of optimizing and regulating the radiation…
Global Biosimilars Market
Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Any differences are carefully evaluated by manufacturers and reviewed by the FDA to ensure the biosimilar meets the Agency’s appropriately high approval standards. According to Gen Consulting Company, the global biosimilars market is projected to reach USD 71,843 million, recording a CAGR of approximately 28.9 percent from 2022 to 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biosimilars market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biosimilars industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for biosimilars can be segmented by type: fusion protein, monoclonal antibodies, recombinant growth factors, recombinant hormones, others. Globally, the monoclonal antibodies segment made up the largest share of the biosimilars market. Biosimilars market is further segmented by application: autoimmune and inflammatory, blood disorders, diabetes, growth hormone deficiency, infectious diseases, oncology, others. The oncology segment captured the largest share of the market in 2021. Based on region, the biosimilars market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, Europe had the largest share in the global biosimilars market.
– fusion protein
– monoclonal antibodies
– recombinant growth factors
– recombinant hormones
– autoimmune and inflammatory
– blood disorders
– growth hormone deficiency
– infectious diseases
– Asia Pacific
– North America
– Rest of the World (RoW)
The report also provides a detailed analysis of several leading biosimilars market vendors that include 3SBio Inc., ALVOTECH ehf., Amgen Inc., Biocad CJSC, Biocon Limited, Bio-Thera Solutions, Ltd.,, Boehringer Ingelheim Pharmaceuticals, Inc., Celltrion, Inc., Chong Kun Dang pharmaceutical Corp, CinnaGen Co., Coherus BioSciences, Inc., Dr. Reddy’s Laboratories Limited, Fresenius Kabi AG, Fujifilm Kyowa Kirin Biologics Co., Ltd., Innovent Biologics, Inc., LG Chem Ltd., Mylan N.V., Nanjing Shunxin Pharmaceuticals Co., Ltd., Outlook Therapeutics, Inc., Pfizer Inc., Reliance Life Sciences, Samsungbioepis Co., Ltd., Sandoz International GmbH, Shanghai Henlius Biotech, Inc., Suzhou Union Biopharm Co., Ltd., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global biosimilars market.
– To classify and forecast the global biosimilars market based on type, application, region.
– To identify drivers and challenges for the global biosimilars market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biosimilars market.
– To identify and analyze the profile of leading players operating in the global biosimilars market.
Why Choose This Report
– Gain a reliable outlook of the global biosimilars market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
Global Biosimilars Market - Report Scope
3SBio Inc., ALVOTECH ehf., Amgen Inc., Biocad CJSC, Biocon Limited, Bio-Thera Solutions Ltd., Boehringer Ingelheim Pharmaceuticals Inc., Celltrion Inc., Chong Kun Dang pharmaceutical Corp, CinnaGen Co., Coherus BioSciences Inc., Dr. Reddy's Laboratories Limited, Fresenius Kabi AG, Fujifilm Kyowa Kirin Biologics Co. Ltd., Innovent Biologics Inc., LG Chem Ltd., Mylan N.V., Nanjing Shunxin Pharmaceuticals Co. Ltd., Outlook Therapeutics Inc., Pfizer Inc., Reliance Life Sciences, Samsungbioepis Co. Ltd., Sandoz International GmbH, Shanghai Henlius Biotech Inc., Suzhou Union Biopharm Co. Ltd., Teva Pharmaceutical Industries Ltd., Zydus Lifesciences Limited
Global NGS library preparation automation market by product (automated instruments, automated kits and consumables), by sequencing type (RNA sequencing, DNA sequencing), by application (research, diagnostics), by institutions (pharmaceutical, laboratories, others), by region (Asia-Pacific (ex. China), Europe, North America, China, RoW (Rest of World)), outlook & forecast, 2023-2029
Global biometrics market by technology (hand geometry, fingerprint, face, iris, vein, voice, others), by end user (BFSI, commercial and retail, government and law enforcement, healthcare, travel and immigration, others), by region (North America, Europe, Asia-Pacific, Rest of World (RoW)), outlook & forecast, 2023-2029